Developing approved therapies for ALS has been painfully slow, as evidenced by the failure of more than 95 per cent of ALS ...

BCLI READ THE FULL BCLI RESEARCH REPORT Business Update Focused on Advancing NurOwn into Phase 3b ENDURANCE Trial BrainStorm ...

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that causes the gradual loss of motor neurons in the brain and spinal cord, leading to muscle weakness, paralysis, and ...

A Jacksonville woman's experience caring for her husband with ALS has formed a foundation to help other families fighting terminal illness.

In the beginning, not even Hynek Wichterle's postdoc thought his idea to slow the progression of amyotrophic lateral ...

Long-term exposure to sulfur dioxide, an air pollutant generated by the burning of fossil fuels, increases the risk of ALS, a ...

SineuGene Therapeutics Co., Ltd. ("SineuGene"), clinical-stage biotechnology company that mainly focuses on gene therapies for neurological disorders, announced today that China's National Medical ...

A new discovery about mutations in a gene that causes ALS may allow researchers to design targeted therapies, a study found.

Answer ALS, in collaboration with ALS Therapy Development Institute (ALS TDI) and Augie's Quest, today announced plans to ...

Stone will be joining Dane — whom she has been friends with "for a long time" — on the long-awaited third season of the HBO ...

Neurizon Therapeutics has started manufacturing the first registration batch of its lead product NUZ-001, being developed to ...

After the loss of his mother to ALS, a Kansas City man gave two Chiefs fans who are ALS patients the tour of a lifetime.